Our study shows an increasing trend in ICI-related NM/P cases over time, emphasizing the need for vigilance in treatment planning and pharmaceutical care [ 13 ].
← all excerpts
Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database.
1
—
—